High glucose activates nuclear factor of activated T cells in native vascular smooth muscle

J Nilsson, LM Nilsson, YW Chen… - … , and vascular biology, 2006 - Am Heart Assoc
J Nilsson, LM Nilsson, YW Chen, JD Molkentin, D Erlinge, MF Gomez
Arteriosclerosis, thrombosis, and vascular biology, 2006Am Heart Assoc
Objective—Hyperglycemia has been suggested to play a role in the development of
vascular disease associated with diabetes. Atypical Ca2+ signaling and gene expression
are characteristic of vascular dysfunction; however, little is known regarding the effects of
high glucose on Ca2+-dependent transcription in the vascular wall. Methods and Results—
Using confocal immunofluorescence, we show that modest elevation of extracellular glucose
(ie, from 2 to 11.5 mmol/L) increased [Ca2+] i, leading to nuclear accumulation of nuclear …
Objective— Hyperglycemia has been suggested to play a role in the development of vascular disease associated with diabetes. Atypical Ca2+ signaling and gene expression are characteristic of vascular dysfunction; however, little is known regarding the effects of high glucose on Ca2+-dependent transcription in the vascular wall.
Methods and Results— Using confocal immunofluorescence, we show that modest elevation of extracellular glucose (ie, from 2 to 11.5 mmol/L) increased [Ca2+]i, leading to nuclear accumulation of nuclear factor of activated T cells (NFAT) in intact cerebral arteries from mouse. This was accompanied by increased NFAT-dependent transcriptional activity. Both the increase in Ca2+ and NFAT activation were prevented by the ectonucleotidase apyrase, suggesting a mechanism involving the release of extracellular nucleotides. We provide evidence that the potent vasoconstrictors and growth stimulators UTP and UDP mediate glucose-induced NFAT activation via P2Y receptors. NFAT nuclear accumulation was inhibited by the voltage-dependent Ca2+ channel blockers verapamil and nifedipine, the calcineurin inhibitor cyclosporine A, and the novel NFAT blocker A-285222. High glucose also regulated glycogen synthase kinase 3β and c-Jun N-terminal kinase activity, yielding decreased kinase activity and reduced export of NFAT from the nucleus, providing additional mechanisms underlying the glucose-induced NFAT activation.
Conclusions— Our results identify the calcineurin/NFAT signaling pathway as a potential metabolic sensor for the arterial smooth muscle response to high glucose.
Am Heart Assoc